JUVE nominates GSK as “M&A Law Firm of the Year 2012“

Press release

 

Munich,5^stSeptember 2012  GSK Stockmann + Kollegen has been nominated by the editorial team of JUVE for their 2012 Awards in the category “Law Firm of the Year for M&A”. The publication JUVE monitors and reports on the German legal market and makes the highly regarded annual JUVE awards for outstanding achievements by legal practices and the legal departments of companies and enterprises.

 

The nomination confirms the substantial progress that  GSK Stockmann + Kollegen has made over the last few years in establishing its corporate practice, and in its development from a practice that focused essentially on real estate, to a dual focus on both real estate and corporate. GSK Stockmann + Kollegen has succeeded in positioning itself as one of the leading independent corporate and real estate practices in Germany.

 

“The nomination as M&A Practice of the Year is really a great honour for us”, comments Peter Ladwig, who is responsible for Corporate/M&A at the Stuttgart office of GSK and who is a member of the firm’s management committee. “The award confirms that our strategy of advising not only on larger M&A and private equity deals, but also with respect to the M&A panels of larger concerns, is a good one. Clients such as Deutsche Post, Deka-Bank, EnBW or Lufthansa endorse that we have also established a good reputation with large firms that are listed on the stock exchange”.

 

Furthermore, the increased internal networking and intensified work between the various practice groups at GSK on M&A projects have made a positive impression on our clients. “In the last two years, we have increased our focus on cross-selling. The JUVE nomination emphasizes that we are on the right track”, explains Andreas Bauer, head of corporate practice group, who, with partners from the fields of real estate and banking, worked last year on major projects for such esteemed clients as Pembroke, Deutsche Post or Lufthansa.  “Our M&A projects are becoming ever more complex and thus require progressively more interdisciplinary agreement and coordination, such as with the areas of real estate, banking, finance or taxation. In this respect, the integration of our comprehensive expertise, particularly in real estate and banking, provides an outstanding competitive advantage.

 

In the future as well, there are plans to extend the GSK practice group for M&A, Andreas Bauer adds: “We expect a further boost in growth from our new Corporate Partner in Frankfurt, Markus Rasner, who joined us at the beginning of August and who has established an impressive track record in the M&A/Private Equity field”.

 

GSK regards South East Asia, among other regions, as offering considerable growth potential. Whether supervising and advising the activities of German firms in South East Asia, or with respect to the growing group of Asian investors in Europe, the GSK M&A Practice Group is ideally placed. In this context, Andreas Bauer explains: “ With our Singapore office, we have been present in Asia since 2009. With our partner Rüdiger Ackermann, the office is now firmly established as the first port of call for German enterprises wishing to invest through Singapore in South East Asia. At the same time, we observe a distinct increase in Asian investors in the direction of Europe and particularly Germany. Therefore, we wish to extend both our inbound and outbound business with Asia”.

 

 

Background on the JUVE Awards:
 

For the JUVE Awards 2012, in 14 of 17 prize categories, 5 legal practices each have been nominated. Furthermore, in each of 3 further prize categories, JUVE has nominated 5 in-house teams for their outstanding performance. The comprehensive research activities of the editorial team of the JUVE Handbook form the basis for the nominations. 

 

The JUVE editorial team supports its selection with information from several thousand discussions and written questionnaires from clients, partners, up-and-coming lawyers and judges. This year, the research for the JUVE Handbook entailed almost 20 000 contacts for the 2012/2013 handbook. In selecting the prizewinners, the JUVE editorial team paid particular attention to specialist skills, as well as strategic orientation, service orientation and future potential.

 

On 25th October, the awards will be made at a gala in the Old Opera in Frankfurt. (Source: JUVE Online, 23.08.2012)

 

Contact:
 

GSK STOCKMANN + KOLLEGEN

Dr. Andreas Bauer

Karl-Scharnagl-Ring 8, 80539 München

Tel.: +49 89 28 81 74-0

Fax: +49 89 28 81 74-44

E-Mail: bauer@gsk.de

 

GSK Stockmann + Kollegen is one of Germany's leadingcorporate and real estate law firms. GSK also focuses on banking/finance and public law.It was founded in 1997 by lawyers from renowned business law firms. Today, more than 135 lawyers and tax advisors are at our clients' disposal at our offices in Berlin, Duesseldorf, Frankfurt, Hamburg, Heidelberg, Munich, Stuttgart, Brussels and in Singapore.

 

For further information, please visit:www.gsk.de

 

In cross-border transactions, GSK is closely cooperating with a selected circle of reputable law firms encompassing the most significant European jurisdictions. These law firms are Nabarro LLP (UK), August & Debouzy (France), Nunziante Magrone (Italy) andRoca Junyent (Spain).This exclusive alliance now has more than 960 lawyers in Europe’s most important financial and economic centres based in 23 offices, covering the European metropolis Brussels as well as North Africa, Singapore and China.

 

For further information, please visit:www.ourwayofdoinginternationalbusiness.com

 

GSK. The Difference.